Exchange: NASDAQ·Updated 06:46 PM EDT

MIRA News

News
all
press releases
Why Is MIRA Pharmaceuticals Stock Gaining Tuesday?
MIRA Pharmaceuticals (NASDAQ: MIRA) stock jumps as MIRA-55 meets key preclinical study milestones for non-opioid inflammatory pain relief.read more...
Benzinga
More News
MIRA Reports Positive 7-Day Dog Study Results for SKNY-1
Press Releases
What's Going On With MIRA Pharma Stock Tuesday?
MIRA Pharmaceuticals (NASDAQ: MIRA) eyes IND submission for Mira-55 after new 2026 data confirms no CNS side effects.read more...
Benzinga
Short Interest in MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) Drops By 13.9%
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA - Get Free Report) saw a significant decrease in short interest in February. As of February 27th, there was short interest totaling 489,206 shares, a decrease...
MarketBeat
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) Short Interest Up 29.4% in February
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA - Get Free Report) was the target of a significant increase in short interest in the month of February. As of February 13th, there was short interest totaling...
MarketBeat
MIRA Pharmaceuticals (NASDAQ:MIRA) Shares Down 6.6% - Time to Sell?
MIRA Pharmaceuticals (NASDAQ:MIRA) Trading Down 6.6% - Time to Sell...
MarketBeat
MIRA Pharmaceuticals (NASDAQ:MIRA) Stock Price Down 6.6% - Time to Sell?
MIRA Pharmaceuticals (NASDAQ:MIRA) Stock Price Down 6.6% - What's Next...
MarketBeat
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) Sees Significant Growth in Short Interest
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA - Get Free Report) was the recipient of a large increase in short interest in the month of December. As of December 31st, there was short interest totaling...
MarketBeat
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) Short Interest Update
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA - Get Free Report) was the target of a large decrease in short interest in the month of December. As of December 15th, there was short interest totaling...
MarketBeat
MIRA Pharmaceuticals (NASDAQ:MIRA) Rating Lowered to Sell at Wall Street Zen
Wall Street Zen downgraded shares of MIRA Pharmaceuticals from a "hold" rating to a "sell" rating in a research note on Saturday...
MarketBeat

Advertisement|Remove ads.